Krebs Biochemicals & Industries Ltd.
KREBSBIO Share PricePharmaceuticals & Drugs
₹72.6
0.1 (0.1%)
As on September 8, 2025
Exchange Scrips: BSE524518NSEKREBSBIOISININE268B01013
Market Cap ₹ 155 Cr
P/E Ratio -7.93
Dividend Yield N/A
Performance
Market performance
Open72.5
High75
Volumes2,087
Prev72.6
Low72.5
As on2025-09-08
Historical performance
1 Year High129.07
3 Year High131.45
5 Year High227.9
1 Year Low66.12
3 Year Low50.65
5 Year Low50.65
Fundamentals
Company Valuation
Market Cap (₹Cr)
155
Face Value (₹)
10
P/E Ratio
-7.93
Dividend Yield
N/A
Investment Returns
1 Year
-10.7%
3 Years
-43.4%
5 Years
-14.6%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 72.58 | Bullish |
| 10-DMA | 72.66 | Bearish |
| 20-DMA | 74.3 | Bearish |
| 50-DMA | 78.8 | Bearish |
| 100-DMA | 79.73 | Bearish |
| 200-DMA | 85.27 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 9112 | 8792 | 9085 | 9419 | 8842 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -7.93.
- 3Y Stock Price CAGR of the stock is -16.5.
- The stock has a beta of 1.4.
- In the last financial year, the company had an EBITDA of ₹-83 Million.
- The company generated revenue of ₹504 Million in the previous financial year.
Krebs Biochemicals & Industries Ltd.
72.60.1 (0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 895191.1
No. of Shares: 12330 (Approx)
Performance:-10.5%
P/L: ₹-104808.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent